Latest News from: Cancer Research Institute

Filters close
Released: 31-Jul-2008 4:00 PM EDT
Cancer Research Institute Names Sixteen New Postdoctoral Fellows
Cancer Research Institute

The Cancer Research Institute, a nonprofit charitable organization dedicated to advancing immunology to conquer cancer, announced that the Fellowship Review Committee of the Institute's Scientific Advisory Council, with the approval of the Institute's Board of Trustees, has named 16 new postdoctoral fellows from its April 2008 application round, awarding more than $2.3 million in research funding through the Irvington Institute Fellowship Program of the Cancer Research Institute.

Released: 27-May-2008 12:25 PM EDT
Cancer Research Institute Announces 2008 Grace and Coley Award Winners
Cancer Research Institute

On June 17, 2008, the Cancer Research Institute (CRI) will host its 22nd Annual Awards Dinner at The Rainbow Room in New York City. More than 300 guests are expected to attend the black-tie dinner, at which CRI will honor philanthropic and corporate leaders and scientists who have made significant contributions to the fight against cancer.

Released: 28-Jan-2008 12:00 AM EST
Cancer Vaccine Consortium and Cancer Vaccine Collaborative Unite under the Cancer Research Institute
Cancer Research Institute

Two global cancer vaccine initiatives comprising industrial and academic efforts have united in close cooperation under the nonprofit Cancer Research Institute to establish a unified voice in the cancer vaccine field, providing a major new resource to academia, industry, and governmental agencies involved in cancer vaccine discovery and development.

16-Nov-2007 1:25 PM EST
Immune System Controls Cancer, Promotes Tumor Dormancy
Cancer Research Institute

Cancer Research Institute supported scientists have proven that dormant cancer cells are actively kept in check by the immune system, while those that escape go on to develop into clinically detectable tumors. A paper online in this week's Nature identifies a crucial stage in the battle, at which point immune defenses stall the expansion of cancer cells that may have managed to dodge past early immunosurveillance.

Released: 31-Oct-2007 3:25 PM EDT
Merger Approved Between Cancer Research Institute and the Irvington Institute for Immunological Research
Cancer Research Institute

Cancer Research Institute, Inc., and the Irvington Institute for Immunological Research, two leading nonprofit immunology research-funding organizations, merge.

Released: 3-Oct-2007 8:40 AM EDT
Cancer & HIV Vaccine Researchers to Meet to Share Data, Lessons Learned
Cancer Research Institute

Cancer and HIV vaccine researchers from around the world will gather for a three-day conference in New York City October 4-6, 2007, along with representatives from industry and health research funding organizations to share and discuss data from the latest clinical and laboratory studies aimed at developing preventive and therapeutic vaccines for both diseases.

Released: 20-Aug-2007 12:35 PM EDT
Immunological Research Organizations Announce Intent to Merge
Cancer Research Institute

The Cancer Research Institute, Inc. and The Irvington Institute for Immunological Research, two leading private immunological research funding organizations headquartered in New York City, have announced today their intention to merge.

Released: 18-Jun-2007 4:00 PM EDT
“Drive Against Prostate Cancer” Mobile Screening Vehicle to be Showcased at Annual CRI Awards
Cancer Research Institute

The nationally touring "Drive Against Prostate Cancer" mobile medical screening vehicle will be on display for public tour during the Cancer Research Institute's 21st annual awards dinner, Tuesday, June 26, from 6 p.m. to 7 p.m., outside New York City's Rainbow Room at Rockefeller Plaza.

Released: 22-May-2007 5:05 PM EDT
Cancer Research Institute Announces 2007 Grace and Coley Award Winners
Cancer Research Institute

Cancer Research Institute honors scientific, philanthropic, and corporate leaders who have made significant contributions to the fight against cancer at its 21st annual awards dinner in New York City on June 26, 2007.

Released: 20-Sep-2006 6:35 PM EDT
A Promising New Vaccination Strategy for Late-Stage Melanoma
Cancer Research Institute

Cancer Vaccine Collaborative scientists announce that results from a study of a new vaccination strategy indicate the vaccine had a favorable impact on disease progression in late-stage melanoma patients. The vaccine is composed of recombinant fowlpox and vaccinia viruses engineered to express the Cancer-Testis antigen NY-ESO-1.

Released: 15-Aug-2006 12:00 PM EDT
Ovarian Cancer Survivor’s Immune System Keeping Her Alive
Cancer Research Institute

After surgery and six months of chemotherapy brought her metastatic ovarian cancer under control, Christine Sable sought less toxic ways to keep her cancer from coming back. She enrolled in an ovarian cancer vaccine study and, three years later, is still cancer free. Her immune system, she says, is keeping her alive.

Released: 30-May-2006 4:45 PM EDT
Awards Dinner Honors Cervical Cancer Vaccine Creator & Others
Cancer Research Institute

The Cancer Research Institute announces the 2006 Coley and Grace Award winners. Coley Award winners include Dr. Harald zur Hausen, Dr. Ian Frazer, Dr. Bruce Beutler, and Dr. Shizuo Akira. Philanthropist Julian H. Robertson, Jr., will receive the Grace Award. The annual gala takes place June 27, 2006, at the Rainbow Room in New York City's Rockefeller Center.

5-May-2006 2:20 PM EDT
Network Seeks Genetic Cause of Innate Cancer Immunity
Cancer Research Institute

The Cancer Research Institute has established a unique collaboration with three other major U.S. research institutions that will work together to unlock the molecular and genetic mysteries behind Zheng Cui's SR/CR mouse's remarkable cancer immunity.

Released: 6-Sep-2005 1:40 PM EDT
Scientist First to Discover How to Overturn Suppressive Immune Response
Cancer Research Institute

Results from a research study supported by the Cancer Research Institute indicates that the suppressive immune tendencies of CD4+ regulatory T cells can be regulated, thus overcoming a huge hurdle faced when crafting a cancer vaccine.


Showing results 151–164 of 164


close
0.12344